期刊文献+

高乌甲素对上腹部手术患者免疫球蛋白水平的影响

Effect of lappaconitine on immunoglobulin levels of patients with upper abdominal surgery
下载PDF
导出
摘要 目的 探讨高乌甲素(LA)对上腹部手术患者IgA、IgM、IgG水平的影响.方法 选择行上腹部手术患者36例,随机数字表法分为3组,高乌甲素组、曲马多组、空白对照组,每组12例.高乌甲素组、曲马多组术前30 min分别静脉滴注高乌甲素8 mg、曲多马100 mg,30 min滴注完毕.麻醉后即开始在高乌甲素组、曲马多组连接电子输注泵,以高乌甲素0.28 mg/ml或曲马多8 mg/ml进行持续背景输注,术后再实施经皮颈动脉血管造影.分别于麻醉用药前30min、术毕即刻、术后24 h、术后48 h取外周静脉血,测定IgA、IgM、IgG.结果 术后48 h空白对照组血清IgA为(1.72±0.27)g/L,与高乌甲素组(1.96±0.36)g/L比较差异有统计学意义(P<0.05);术后24 h空白对照组、曲马多组血清IgM分别为(1.32±0.18)、(1.40±0.20)g/L,较术组麻醉用药前降低,与高乌甲素组(1.60±0.23)g/L比较差异有统计学意义(P<0.05);空白对照组术毕即刻、术后24 h血清IgG降低,与高乌甲素组比较差异有统计学意义(P<0.05).结论 观察患者不同时段IgA、IgM、IgG的水平,发现高乌甲素于上腹部手术后在一定程度上可稳定血清IgA、IgM、IgG水平. Objective To detect lappaconitine(LA) effect on the levels of IgA, IgM, IgG in upper abdominal surgery patients. Methods Thirty-six patients with upper abdominal surgery were randomized in to 3 groups with 12 in each group( LA group, the tramadol group and the placebo group). Patients in LA group and tramadol group received intravenous drop of LA 8 mg and tramadol 100 mg in 30 min, then received background pump supply of LA 0.28 mg/ml or tramadol 8 mg/ml, and PCA was conducted postoperatively. Peripheral venous blood was taken (30 min before anesthesia, immdiately after the hemorrhoid operation and at postoperative 24th 48th h)for IgA,IgM and IgG examination. Results IgA level in the placebo group was much lower at postoperative 48 h than that in the LA group(P〈0.05);IgM level was much lower in placebo group and tramadol group at 24 h than that in LA group(P〈0.05). The IgG level immediately after operation and at the postoperative 24th h in placebo group was much lower than that in LA group (P〈0.05). Conclusion Lappaconitine can stabilize IgA, IgM and IgG levels after upper abdominal surgery.
出处 《中国医药》 2010年第10期915-916,共2页 China Medicine
关键词 上腹部 手术 高乌甲素 Upper abdominal Surgery Lappaconitine
  • 相关文献

参考文献10

二级参考文献51

  • 1何玉清,张锡宝,费实,刘玉梅,吴志华.银屑病患者外周血Th1细胞分化偏态性分析[J].岭南皮肤性病科杂志,2002,9(1):1-4. 被引量:12
  • 2何晖,翟明.抗CD_(20)单克隆抗体美罗华的临床研究进展[J].中国医师杂志,2006,8(3):431-432. 被引量:6
  • 3朱云松,徐安平,何恢绪,范礼佩,聂海波,吕军,胡卫列,李清荣,邓志雄.单剂半量赛尼哌预防移植肾急性排斥的临床观察[J].南方医科大学学报,2006,26(12):1818-1820. 被引量:2
  • 4黄永年,邢玉馥.溃疡性结肠炎发病机制的实验研究[J].中国肛肠病杂志,1997,17(1):3-5. 被引量:19
  • 5陈慰峰 主编.医学免疫学 第3版[M].北京:人民卫生出版社,2001.35~43.
  • 6Vose J M, Link B K, Grossbard M L, et al. Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma [J]. J Clin Oncol, 2001,19(2) :389-397.
  • 7Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma [J]. N Engl J Med, 2002,346(4):235-242.
  • 8Foren A, Lobuglio A F. History of antibody therapy for non Hodgkin's lymphoma [J]. Semin Oncol, 2003,30 (Suppl 17) : 1-5.
  • 9Crillo Lopez A J, Cheson B D, Homing S J, et al. Response criteria for NHL: importance of "normal" lymph node size and correlations with response rates [ J ]. Ann Oncol, 2000,11 (4) : 399-408.
  • 10Kokel F, Derticarart S, Presanl G, et al. An analysis of T lymphocyte subpopulations is psoriasis using monoclonal antibodies[ J]. Acta Derm Verercol, 1983,63 (5) :422 - 424.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部